Diadema Partners »

Puretech Health shares owned by Diadema Partners

Quarter-by-quarter ownership of Puretech Health (PRTC) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Puretech Health

Tip: Access up to 7 years of quarterly data

All positions including Puretech Health held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Puretech Health by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $136k 7.3k 18.50

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Puretech Health

Pentwater Capital Management
Millennium Management
Diadema Partners
UBS Group
SBI Securities

View all funds holding Puretech Health